 |
 |
The following appeared in a financial news general release: ******* Biotech leader Amgen rose after an analyst at Salomon Brothers predicted the company will disclose positive breakthroughs for its treatment for Parkinson's disease in a report to be presented next week to the Society of Neuroscience. Amgen added $1.75, to $49.50. ******* In other statements I've heard, this announcement concerns glia derived neural trophic factor. One announcement said this would be available in 1996 to patients. Until the actual presentation is made, everything is speculation. Regards, Alan Bonander [log in to unmask]